Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFreeman, L.en
dc.contributor.authorLam, A.en
dc.contributor.authorPetcu, E.en
dc.contributor.authorSmith, R.en
dc.contributor.authorSalajegheh, A.en
dc.contributor.authorDiamond, P.en
dc.contributor.authorZannettino, A.en
dc.contributor.authorEvdokiou, A.en
dc.contributor.authorLuff, J.en
dc.contributor.authorWong, P.en
dc.contributor.authorKhalil, D.en
dc.contributor.authorWaterhouse, N.en
dc.contributor.authorVari, F.en
dc.contributor.authorRice, A.en
dc.contributor.authorCatley, L.en
dc.contributor.authorHart, D.en
dc.contributor.authorVuckovic, S.en
dc.identifier.citationJournal of Immunology, 2011; 187(8):3987-3996en
dc.description.abstractThe graft-versus-myeloma (GVM) effect represents a powerful form of immune attack exerted by alloreactive T cells against multiple myeloma cells, which leads to clinical responses in multiple myeloma transplant recipients. Whether myeloma cells are themselves able to induce alloreactive T cells capable of the GVM effect is not defined. Using adoptive transfer of T naive cells into myeloma-bearing mice (established by transplantation of human RPMI8226-TGL myeloma cells into CD122+ cell-depleted NOD/SCID hosts), we found that myeloma cells induced alloreactive T cells that suppressed myeloma growth and prolonged survival of T cell recipients. Myeloma-induced alloreactive T cells arising in the myeloma-infiltrated bones exerted cytotoxic activity against resident myeloma cells, but limited activity against control myeloma cells obtained from myeloma-bearing mice that did not receive T naive cells. These myeloma-induced alloreactive T cells were derived through multiple CD8+ T cell divisions and enriched in double-positive (DP) T cells coexpressing the CD8αα and CD4 coreceptors. MHC class I expression on myeloma cells and contact with T cells were required for CD8+ T cell divisions and DP-T cell development. DP-T cells present in myeloma-infiltrated bones contained a higher proportion of cells expressing cytotoxic mediators IFN-γ and/or perforin compared with single-positive CD8+ T cells, acquired the capacity to degranulate as measured by CD107 expression, and contributed to an elevated perforin level seen in the myeloma-infiltrated bones. These observations suggest that myeloma-induced alloreactive T cells arising in myeloma-infiltrated bones are enriched with DP-T cells equipped with cytotoxic effector functions that are likely to be involved in the GVM effect.en
dc.description.statementofresponsibilityLisa M. Freeman, Alfred Lam, Eugene Petcu, Robert Smith, Ali Salajegheh, Peter Diamond, Andrew Zannettino, Andreas Evdokiou, John Luff, Pooi-Fong Wong, Dalia Khalil, Nigel Waterhouse, Frank Vari, Alison M. Rice, Laurence Catley, Derek N. J. Hart and Slavica Vuckovicen
dc.publisherAmer Assoc Immunologistsen
dc.rightsCopyright © 2011 by The American Association of Immunologists, Inc.en
dc.subjectCD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Animals; Mice, Inbred NOD; Humans; Mice; Mice, SCID; Multiple Myeloma; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Adoptive Transfer; Transplantation, Homologous; Flow Cytometry; Cell Separation; Immunohistochemistry; Cytotoxicity, Immunologic; Graft vs Tumor Effect; Femaleen
dc.titleMyeloma-induced alloreactive T cells arising in myeloma-infiltrated bones include double-positive CD8⁺CD4⁺ T cells: evidence from myeloma-bearing mouse modelen
dc.title.alternativeMyeloma-induced alloreactive T cells arising in myeloma-infiltrated bones include double-positive CD8(+)CD4(+) T cells: evidence from myeloma-bearing mouse modelen
dc.typeJournal articleen
pubs.library.collectionMedicine publicationsen
dc.identifier.orcidZannettino, A. [0000-0002-6646-6167]en
dc.identifier.orcidEvdokiou, A. [0000-0001-8321-9806]en
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.